APP Co-Management and E-Consults for Urinary Incontinence
(OUTPACE Trial)
Trial Summary
What is the purpose of this trial?
The burden of urinary incontinence (UI) on American women is immense in both human and financial terms, and continues to rise with the aging US population. Although numerous non-surgical management strategies have proven efficacy for both stress and urge urinary incontinence, there remains a lack of appropriate UI management in the primary care setting. The goal of this multi-site cluster randomized comparative effectiveness trial is to compare the effects of two methods of nonsurgical UI care delivery - electronic consult vs. advanced practice provider (APP) co-management. These two evidence-based, practice-changing strategies are designed to improve the quality of care for an ethnically diverse population of women with UI, and, by reducing deficits in care, obtain better patient-reported outcomes. Both arms of the study will include basic physician education (academic detailing) and electronic clinical decision support. In Arm 1, the investigators will implement an electronic referral system (electronic referral), in which specialists will electronically review referrals and make additional recommendations if appropriate primary UI care was not provided. In Arm 2, Advanced Practice Provider (APP) co-management will reduce the burden of care on the PCPs by providing UI care, patient education, and assisting with patient self-management through dedicated televisits (APP co-management).
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment APP Co-Management and E-Consults for Urinary Incontinence?
Is app-based treatment for urinary incontinence safe for humans?
How is the APP Co-Management and E-Consult treatment for urinary incontinence different from other treatments?
Eligibility Criteria
This trial is for women over 18 who experience urinary incontinence, can communicate in English or Spanish, and have a primary care physician at one of the participating sites: UCSD, UCLA, KUMC. They must acknowledge their condition using an incontinence screening tool.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive nonsurgical UI care through either electronic consult or APP co-management
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- APP Co-management
- E-consult
APP Co-management is already approved in United States for the following indications:
- Urinary Incontinence Management
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor
Patient-Centered Outcomes Research Institute
Collaborator
University of California, Los Angeles
Collaborator
University of Kansas
Collaborator